Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
Kymera pivots to immunology, seeks partners for cancer assets
Kymera is pivoting to immunology, with plans to only develop cancer programs beyond phase 1 through partnerships.
Gabrielle Masson
Nov 1, 2024 11:46am
Jade pockets Aerovate in reverse merger
Oct 31, 2024 3:03pm
Topas says celiac candidate shines but keeps data under wraps
Oct 15, 2024 8:08am
Candid flashes big ambitions with $370M debut
Sep 9, 2024 9:00am
Bicara, Zenas seek IPOs to push late-phase assets toward market
Aug 23, 2024 5:07am
J&J vets burst into biotech with $165M Third Arc series A
Jul 23, 2024 10:00am